Balchem Financials

BCPC Stock  USD 180.81  3.32  1.87%   
Balchem is doing better financially today then in previous quarter. It has a moderate probability of reporting better financial numbers in March. At present, Balchem's Short and Long Term Debt Total is projected to increase significantly based on the last few years of reporting. The current year's Other Current Liabilities is expected to grow to about 114.9 M, whereas Common Stock Shares Outstanding is forecasted to decline to about 30.2 M.
 
Black Monday
 
Oil Shock
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes

Balchem Balance Sheet Chart

At present, Balchem's Short and Long Term Debt Total is projected to increase significantly based on the last few years of reporting. The current year's Other Current Liabilities is expected to grow to about 114.9 M, whereas Common Stock Shares Outstanding is forecasted to decline to about 30.2 M.
Key indicators impacting Balchem's financial strength include:
Current ValueLast YearChange From Last Year 10 Year Trend
Net Profit Margin0.0750.12
Way Down
Very volatile
Return On Assets0.110.0938
Fairly Up
Slightly volatile
Return On Equity0.170.13
Significantly Up
Slightly volatile
Debt Equity Ratio0.330.21
Way Up
Very volatile
Operating Income220.9 M210.3 M
Sufficiently Up
Slightly volatile
Current Ratio2.121.79
Fairly Up
Slightly volatile
Investors should never underestimate Balchem's ability to pay suppliers on time, ensure interest payments are not accumulating, and correctly time where and how to reinvest extra cash. Individual investors need to research Balchem's cash flow, debt, and profitability to make informed and accurate decisions about investing in Balchem.

Net Income

155.13 Million

  
Build AI portfolio with Balchem Stock
Understanding current and past Balchem Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Balchem's financial statements are interrelated, with each one affecting the others. For example, an increase in Balchem's assets may result in an increase in income on the income statement.

Balchem Earnings Geography

Please note, the presentation of Balchem's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Balchem's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Balchem's management manipulating its earnings.

Balchem Stock Summary

Balchem competes with Sensient Technologies, Sasol, Axalta Coating, Element Solutions, and SSR Mining. Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. Balchem Corporation was incorporated in 1967 and is headquartered in New Hampton, New York. Balchem Cp operates under Specialty Chemicals classification in the United States and is traded on NASDAQ Exchange. It employs 1382 people.
Specialization
Basic Materials, Specialty Chemicals
InstrumentUSA Stock View All
ExchangeNASDAQ Exchange
ISINUS0576652004
Business Address5 Paragon Drive,
SectorChemicals
IndustryMaterials
BenchmarkDow Jones Industrial
Websitewww.balchem.com
Phone845 326 5600
CurrencyUSD - US Dollar

Balchem Key Financial Ratios

Balchem Key Balance Sheet Accounts

202120222023202420252026 (projected)
Total Assets1.2B1.6B1.6B1.6B1.8B1.9B
Other Current Liab85.2M76.4M83.8M95.1M109.4M114.9M
Net Debt5.3M394.1M265.9M158.5M182.3M191.4M
Retained Earnings732.1M814.5M897.5M997.5M1.1B1.2B
Net Receivables117.4M131.6M125.3M119.7M137.6M144.5M
Inventory91.1M119.7M109.5M130.8M150.4M157.9M
Other Current Assets10.5M18.0M15.0M13.8M15.9M8.0M
Total Liab322.3M686.2M543.2M425.5M489.3M513.7M
Total Current Assets322.2M335.8M314.2M313.8M360.8M378.9M
Short Term Debt2.4M4.0M4.2M3.3M3.8M6.5M
Cash103.2M66.6M64.4M49.5M56.9M46.5M
Accounts Payable56.2M57.3M55.5M54.7M63.0M66.1M
Intangible Assets94.7M213.3M191.2M165.1M189.8M199.3M
Common Stock2.2M2.1M2.2M2.2M2.5M1.6M
Other Liab64.6M68.0M69.9M89.6M103.0M108.2M
Long Term Debt108.6M440.6M309.6M190M218.5M149.4M
Good Will523.9M769.5M778.9M780.0M897.0M941.9M
Other Assets4.1M19.7M11.7M10.8M12.4M13.1M
Net Tangible Assets75.7M298.8M258.4M168.8M194.1M129.0M
Capital Surpluse174.2M173.0M147.7M128.8M148.1M135.9M

Balchem Key Income Statement Accounts

202120222023202420252026 (projected)
Interest Expense2.5M10.3M22.6M16.5M19.0M20.0M
Total Revenue799.0M942.4M922.4M953.7M1.1B1.2B
Gross Profit243.2M280.5M302.1M336.2M386.6M406.0M
Operating Income127.5M145.2M159.2M182.9M210.3M220.9M
Ebit127.7M144.0M159.9M183.0M210.4M220.9M
Ebitda176.6M195.9M214.8M231.0M265.6M278.9M
Cost Of Revenue555.8M661.9M620.4M617.5M710.1M745.6M
Income Before Tax125.2M133.7M137.3M166.5M191.4M201.0M
Net Income96.1M105.4M108.5M128.5M147.7M155.1M
Income Tax Expense29.1M28.4M28.7M38.0M43.7M45.9M
Research Development13.5M12.2M15.0M16.8M19.3M20.3M
Tax Provision29.1M28.4M28.7M38.0M43.7M26.0M
Net Interest Income(2.5M)(10.3M)(22.6M)(16.5M)(14.9M)(15.6M)

Balchem Key Cash Accounts

202120222023202420252026 (projected)
Change To Inventory(21.0M)(7.8M)10.5M(22.8M)(20.5M)(19.5M)
Free Cash Flow123.1M88.2M145.9M146.3M168.3M176.7M
Depreciation48.9M51.8M54.9M48.0M55.2M57.9M
Capital Expenditures37.4M50.3M37.9M35.7M41.0M43.1M
Net Income96.1M105.4M108.5M128.5M147.7M155.1M
Change In Cash18.7M(36.7M)(2.1M)(14.9M)(13.4M)(12.8M)
Other Non Cash Items(257K)1.7M(5.0M)1.8M1.6M1.7M
Dividends Paid18.7M20.7M(22.9M)(25.6M)(23.0M)(21.9M)
End Period Cash Flow103.2M66.6M64.4M49.5M56.9M46.5M
Change To Netincome2.8M6.1M4.6M5.2M6.0M6.3M
Change Receivables11.6M(3.6M)(20.7M)(3.6M)(3.3M)(3.4M)
Net Borrowings(55.2M)299.8M(131.2M)(119.8M)(107.8M)(102.4M)
Investments(35.3M)(150K)(37.4M)(59.7M)(68.7M)(72.1M)

Balchem Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Balchem's current stock value. Our valuation model uses many indicators to compare Balchem value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Balchem competition to find correlations between indicators driving Balchem's intrinsic value. More Info.
Balchem is rated fifth in return on equity category among its peers. It is rated third in return on asset category among its peers reporting about  0.65  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Balchem is roughly  1.53 . At present, Balchem's Return On Equity is projected to slightly decrease based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Balchem's earnings, one of the primary drivers of an investment's value.

Balchem's Earnings Breakdown by Geography

Most indicators from Balchem's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Balchem current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Balchem. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation.
For information on how to trade Balchem Stock refer to our How to Trade Balchem Stock guide.At present, Balchem's Enterprise Value is projected to increase significantly based on the last few years of reporting.
 2023 2024 2025 2026 (projected)
Gross Profit302.1M336.2M386.6M406.0M
Total Revenue922.4M953.7M1.1B1.2B

Balchem fundamental ratios Correlations

0.720.940.970.970.990.690.960.990.980.670.790.980.10.90.880.920.84-0.36-0.33-0.33-0.10.940.920.490.51
0.720.560.670.540.670.970.520.750.670.460.990.610.30.570.960.50.420.01-0.46-0.46-0.350.590.920.420.43
0.940.560.960.950.940.540.950.930.940.620.620.94-0.050.860.750.910.81-0.36-0.3-0.3-0.070.920.810.430.46
0.970.670.960.950.970.640.950.970.960.650.720.960.130.880.840.920.82-0.29-0.33-0.33-0.060.950.880.470.5
0.970.540.950.950.980.511.00.950.960.650.620.980.020.90.740.960.88-0.44-0.24-0.24-0.010.940.810.450.48
0.990.670.940.970.980.650.970.990.980.660.740.980.080.920.840.920.83-0.42-0.34-0.34-0.10.940.890.470.5
0.690.970.540.640.510.650.50.740.630.340.960.590.310.540.930.50.27-0.08-0.67-0.67-0.380.560.90.250.26
0.960.520.950.951.00.970.50.950.950.620.60.990.00.870.730.970.87-0.46-0.24-0.240.010.950.790.420.44
0.990.750.930.970.950.990.740.950.960.630.810.970.130.890.90.920.77-0.37-0.42-0.42-0.130.920.940.440.47
0.980.670.940.960.960.980.630.950.960.710.740.950.110.910.840.870.86-0.36-0.27-0.27-0.160.950.870.560.58
0.670.460.620.650.650.660.340.620.630.710.50.620.150.740.570.540.74-0.010.150.15-0.050.610.60.930.94
0.790.990.620.720.620.740.960.60.810.740.50.680.280.640.980.560.49-0.08-0.45-0.45-0.320.650.950.440.45
0.980.610.940.960.980.980.590.990.970.950.620.680.040.860.790.960.85-0.43-0.31-0.31-0.050.960.850.410.43
0.10.3-0.050.130.020.080.310.00.130.110.150.280.040.160.250.01-0.040.29-0.23-0.230.010.110.240.170.17
0.90.570.860.880.90.920.540.870.890.910.740.640.860.160.740.810.77-0.23-0.26-0.26-0.120.80.80.60.62
0.880.960.750.840.740.840.930.730.90.840.570.980.790.250.740.690.61-0.14-0.44-0.44-0.270.770.980.480.49
0.920.50.910.920.960.920.50.970.920.870.540.560.960.010.810.690.78-0.42-0.32-0.320.10.890.780.310.34
0.840.420.810.820.880.830.270.870.770.860.740.490.85-0.040.770.610.78-0.250.230.230.060.850.640.650.67
-0.360.01-0.36-0.29-0.44-0.42-0.08-0.46-0.37-0.36-0.01-0.08-0.430.29-0.23-0.14-0.42-0.250.310.310.06-0.43-0.160.160.15
-0.33-0.46-0.3-0.33-0.24-0.34-0.67-0.24-0.42-0.270.15-0.45-0.31-0.23-0.26-0.44-0.320.230.311.00.29-0.27-0.470.320.31
-0.33-0.46-0.3-0.33-0.24-0.34-0.67-0.24-0.42-0.270.15-0.45-0.31-0.23-0.26-0.44-0.320.230.311.00.29-0.27-0.470.320.31
-0.1-0.35-0.07-0.06-0.01-0.1-0.380.01-0.13-0.16-0.05-0.32-0.050.01-0.12-0.270.10.060.060.290.29-0.07-0.22-0.07-0.06
0.940.590.920.950.940.940.560.950.920.950.610.650.960.110.80.770.890.85-0.43-0.27-0.27-0.070.80.430.45
0.920.920.810.880.810.890.90.790.940.870.60.950.850.240.80.980.780.64-0.16-0.47-0.47-0.220.80.480.49
0.490.420.430.470.450.470.250.420.440.560.930.440.410.170.60.480.310.650.160.320.32-0.070.430.481.0
0.510.430.460.50.480.50.260.440.470.580.940.450.430.170.620.490.340.670.150.310.31-0.060.450.491.0
Click cells to compare fundamentals

Balchem Account Relationship Matchups

Balchem fundamental ratios Accounts

202120222023202420252026 (projected)
Total Assets1.2B1.6B1.6B1.6B1.8B1.9B
Other Current Liab85.2M76.4M83.8M95.1M109.4M114.9M
Net Debt5.3M394.1M265.9M158.5M182.3M191.4M
Retained Earnings732.1M814.5M897.5M997.5M1.1B1.2B
Net Receivables117.4M131.6M125.3M119.7M137.6M144.5M
Inventory91.1M119.7M109.5M130.8M150.4M157.9M
Other Current Assets10.5M18.0M15.0M13.8M15.9M8.0M
Total Liab322.3M686.2M543.2M425.5M489.3M513.7M
Total Current Assets322.2M335.8M314.2M313.8M360.8M378.9M
Short Term Debt2.4M4.0M4.2M3.3M3.8M6.5M
Cash103.2M66.6M64.4M49.5M56.9M46.5M
Accounts Payable56.2M57.3M55.5M54.7M63.0M66.1M
Intangible Assets94.7M213.3M191.2M165.1M189.8M199.3M
Common Stock2.2M2.1M2.2M2.2M2.5M1.6M
Other Liab64.6M68.0M69.9M89.6M103.0M108.2M
Long Term Debt108.6M440.6M309.6M190M218.5M149.4M
Good Will523.9M769.5M778.9M780.0M897.0M941.9M
Other Assets4.1M19.7M11.7M10.8M12.4M13.1M
Net Tangible Assets75.7M298.8M258.4M168.8M194.1M129.0M
Capital Surpluse174.2M173.0M147.7M128.8M148.1M135.9M
Today, most investors in Balchem Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Balchem's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Balchem growth as a starting point in their analysis.

Price Earnings To Growth Ratio

1.58

At present, Balchem's Price Earnings To Growth Ratio is projected to slightly grow based on the last few years of reporting.

Balchem February 15, 2026 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Balchem help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Balchem. We use our internally-developed statistical techniques to arrive at the intrinsic value of Balchem based on widely used predictive technical indicators. In general, we focus on analyzing Balchem Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Balchem's daily price indicators and compare them against related drivers.

Complementary Tools for Balchem Stock analysis

When running Balchem's price analysis, check to measure Balchem's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Balchem is operating at the current time. Most of Balchem's value examination focuses on studying past and present price action to predict the probability of Balchem's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Balchem's price. Additionally, you may evaluate how the addition of Balchem to your portfolios can decrease your overall portfolio volatility.
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios